Summary:
Click image to enlarge
This is a Phase 2 clinical research study designed to examine the effect of an investigational drug in patients with fatty liver disease, more specifically patients with NASH and some evidence of liver scarring or liver fibrosis.
Qualified Participants Must:
• Be at least 18 years of age
•
Have NASH or non-alcoholic steatohepatitis
•
Have at least 2 of the following: Type 2 diabetes, obesity, high blood pressure, elevated liver enzymes
Qualified Participants May Receive:
If you qualify, you will receive study related:
- Medication
- Diagnostic procedures
- Physical Exams
- Laboratory tests
- Compensation for time and travel